» Articles » PMID: 37078237

New Insights into the Pathophysiology of Methylmalonic Acidemia

Overview
Publisher Wiley
Date 2023 Apr 20
PMID 37078237
Authors
Affiliations
Soon will be listed here.
Abstract

Methylmalonic acidemia (MMA) is a severe inborn error of metabolism that is characterized by pleiotropic metabolic perturbations and multiorgan pathology. Treatment options are limited and non-curative as the underlying causative molecular mechanisms remain unknown. While earlier studies have focused on the potential direct toxicity of metabolites such as methylmalonic and propionic acid as a mechanism to explain disease pathophysiology, new observations have revealed that aberrant acylation, specifically methylmalonylation, is a characteristic feature of MMA. The mitochondrial sirtuin enzyme SIRT5 is capable of recognizing and removing this PTM, however, reduced protein levels of SIRT5 along with other mitochondrial SIRTs 3 and 4 in MMA and potentially reduced function of all three indicates aberrant acylation may require clinical intervention. Therefore, targeting posttranslational modifications may represent a new therapeutic approach to treat MMA and related organic acidemias.

Citing Articles

Costunolide Ameliorates the Methylmalonic Acidemia Via the PINK1/Parkin Pathway.

Lu X, Zheng H, Bai H, Wang Y, Li L, Ma B Neurochem Res. 2025; 50(2):115.

PMID: 40053170 DOI: 10.1007/s11064-025-04364-4.


Methylmalonic acid at the serum level in the elderly contributes to cell growth via mitochondrial dysfunction in colorectal cancer cell spheroids.

Tanaka A, Murakami C, Yamamoto H Biochem Biophys Rep. 2025; 41:101909.

PMID: 39886070 PMC: 11780164. DOI: 10.1016/j.bbrep.2024.101909.


Isolated methylmalonic acidemia in Mexico: Genotypic spectrum, report of two novel MMUT variants and a possible synergistic heterozygosity effect.

Fernandez-Lainez C, Vela-Amieva M, Reyna-Fabian M, Fernandez-Hernandez L, Guillen-Lopez S, Lopez-Mejia L Mol Genet Metab Rep. 2024; 41:101155.

PMID: 39494389 PMC: 11530693. DOI: 10.1016/j.ymgmr.2024.101155.


Long-term follow-up of Chinese patients with methylmalonic acidemia of the cblC and mut subtypes.

Hao L, Ling S, Ding S, Qiu W, Zhang H, Zhang K Pediatr Res. 2024; .

PMID: 39306609 DOI: 10.1038/s41390-024-03581-x.


Disruption of Mitochondrial Quality Control in Inherited Metabolic Disorders.

Marcuzzo M, de Andrade Silveira J, Streck E, Vockley J, Leipnitz G Mol Neurobiol. 2024; .

PMID: 39251562 DOI: 10.1007/s12035-024-04467-z.


References
1.
Gabbi P, Nogueira V, Haupental F, Rodrigues F, do Nascimento P, Barbosa S . Ammonia role in glial dysfunction in methylmalonic acidemia. Toxicol Lett. 2018; 295:237-248. DOI: 10.1016/j.toxlet.2018.06.1070. View

2.
Hirschey M, Shimazu T, Huang J, Schwer B, Verdin E . SIRT3 regulates mitochondrial protein acetylation and intermediary metabolism. Cold Spring Harb Symp Quant Biol. 2011; 76:267-77. DOI: 10.1101/sqb.2011.76.010850. View

3.
Park J, Chen Y, Tishkoff D, Peng C, Tan M, Dai L . SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways. Mol Cell. 2013; 50(6):919-30. PMC: 3769971. DOI: 10.1016/j.molcel.2013.06.001. View

4.
Ogura M, Nakamura Y, Tanaka D, Zhuang X, Fujita Y, Obara A . Overexpression of SIRT5 confirms its involvement in deacetylation and activation of carbamoyl phosphate synthetase 1. Biochem Biophys Res Commun. 2010; 393(1):73-8. DOI: 10.1016/j.bbrc.2010.01.081. View

5.
Sadhukhan S, Liu X, Ryu D, Nelson O, Stupinski J, Li Z . Metabolomics-assisted proteomics identifies succinylation and SIRT5 as important regulators of cardiac function. Proc Natl Acad Sci U S A. 2016; 113(16):4320-5. PMC: 4843474. DOI: 10.1073/pnas.1519858113. View